• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment
Int J Environ Res Public Health. 2023 Jan 19;20(3):1835. doi: 10.3390/ijerph20031835.ABSTRACTWe are presenting an overview of the retracted clinical trials about the Coronavirus Disease (COVID)-19 published in PubMed using the descriptors ((COVID-19 OR SARS-CoV-2) AND (Clinical Trial)). We collected the information for i) the first author's country; ii) the journal name where the study was published; iii) the impact factor of the journal; iv) the main objective of the study; v) methods including population, intervention, study design, and outcomes; and vi) results and conclusions. We collected complete information from the...
Source: Cell Research - February 11, 2023 Category: Cytology Authors: Felipe Eduardo Valencise Camila Vantini Capasso Palamim Fernando Augusto Lima Marson Source Type: research

IJERPH, Vol. 20, Pages 1835: Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment
arson We are presenting an overview of the retracted clinical trials about the Coronavirus Disease (COVID)-19 published in PubMed using the descriptors ((COVID-19 OR SARS-CoV-2) AND (Clinical Trial)). We collected the information for i) the first author’s country; ii) the journal name where the study was published; iii) the impact factor of the journal; iv) the main objective of the study; v) methods including population, intervention, study design, and outcomes; and vi) results and conclusions. We collected complete information from the retraction notes published by the journals and the number of publica...
Source: International Journal of Environmental Research and Public Health - January 19, 2023 Category: Environmental Health Authors: Felipe Eduardo Valencise Camila Vantini Capasso Palamim Fernando Augusto Lima Marson Tags: Brief Report Source Type: research

Safety of uro-oncology practice and robot-assisted surgery during the peak of COVID-19 pandemic: A report from India
Conclusions: We can continue treating needy cancer patients with minimal risk by taking all precautions. Our initial experience of managing uro-oncology cases during this pandemic is encouraging. Robotic surgeries can be safely performed.
Source: Journal of Cancer Research and Therapeutics - November 16, 2022 Category: Cancer & Oncology Authors: Preetham Dev TB Yuvaraja Santosh S Waigankar Sharmila Ranade Abhinav P Pednekar Varun Agarwal Archan Khandekar Naresh Badlani Ashish Asari Source Type: research

Clinical course and outcomes of COVID-19 in kidney transplant recipients
Conclusion: COVID-19 in kidney transplant recipients is associated with a high risk of AKI and significant mortality.
Source: Indian Journal of Nephrology - October 12, 2022 Category: Urology & Nephrology Authors: Divya Bajpai Satarupa Deb Sreyashi Bose Chintan P Gandhi Tulsi Modi Abhinav Katyal Nikhil Saxena Ankita Patil Sunil Patil Sayali Thakare Atim Pajai Ashwathy Haridas Vaibhav S Keskar Sunil Y Jawale Amar G Sultan Gita Nataraj Nayana Ingole Tukaram E Jamale Source Type: research

In search for a panacea for coronavirus disease-19: Analysis of ongoing clinical trials for the management of coronavirus disease-19 pandemic in India
CONCLUSIONS: In response to the COVID-19 pandemic, Indian researchers came forward from all the systems of medicine to evaluate interventions for prophylaxis or treatment of the disease. The involvement of AYUSH systems of medicine was specifically more in this regard. A wide variation and heterogeneity in doses and outcomes were observed in trial designs which might make it difficult to generalize the study results when they are made available. Urgent analyses of studies involving interventions on the treatment advisory of the Government may help the healthcare providers take more informed decisions for managing COVID-19 patients in India.
Source: Indian Journal of Pharmacology - October 6, 2022 Category: Drugs & Pharmacology Authors: Nidhi Maheshwari Vandana Roy Source Type: research

Prophylactic use of hydroxychloroquine (HCQS) in COVID-19: A questionnaire-based study in health care professionals
Conclusion: The majority of participants felt that despite a lack of proven efficacy, ICMR guidelines on HCQS prophylaxis in COVID-19 are justified considering the pandemic situation. Our study also found that HCQS is well tolerated by participants and there was no reported serious adverse effect and cardiac-related side effects among them.
Source: Annals of African Medicine - July 6, 2022 Category: African Health Authors: Gaurav Manikrao Rangari Sushil Sharma Roza Gorakhnath Bhaisare C Madhavrao Arup Kumar Misra Source Type: research

COVID-19 in hemodialysis patients: Experience from a Western Indian center
Conclusion: CKD-5D patients with COVID-19 were less likely to present with the classical syndrome of fever and respiratory distress compared with reports from the general population and had higher mortality. Only disease severity and high CRP (>175 mg/L) were predictive of mortality in our cohort.
Source: Indian Journal of Nephrology - June 6, 2022 Category: Urology & Nephrology Authors: Subho Banerjee Himanshu V Patel Divyesh P Engineer Vaibhav Gupta Harshit Patel Aakash Gupta Pankaj R Shah Vivek B Kute Source Type: research

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 among healthcare workers: Initial experience from India
CONCLUSION: HCQ is safe at the recommended dose for pre-exposure prophylaxis of COVID-19.PMID:35495846 | PMC:PMC9051734 | DOI:10.4103/jfmpc.jfmpc_1177_21
Source: Primary Care - May 2, 2022 Category: Primary Care Authors: Harshith B Kadnur Anivita Aggarwal Manish Soneja Komal Singh Ankit Mittal Neeraj Nischal Praveen Tirlangi Adil Rashid Khan Devashish Desai Ankesh Gupta Arvind Kumar Pankaj Jorwal Ashutosh Biswas Ravindra Mohan Pandey Naveet Wig Randeep Guleria Source Type: research

Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
J Korean Med Sci. 2022 Feb 7;37(5):e32. doi: 10.3346/jkms.2022.37.e32.ABSTRACTDermatomyositis (DM) is one of the uncommon multi-organ idiopathic inflammatory myopathies that has been reported following the hepatitis B, Influenza, tetanus toxoid, H1N1, and BCG vaccines. However, an association with the coronavirus disease 2019 (COVID-19) vaccine is yet to be reported. In this case, we present the case of a 43-year-old Asian Indian female who was diagnosed with DM 10 days after receiving the second dosage of BNT162b2 mRNA COVID-19 vaccination, in the absence of any additional triggering factors. The diagnosis was established...
Source: Journal of Korean Medical Science - February 8, 2022 Category: Biomedical Science Authors: Wesam Gouda Anwar Albasri Faisal Alsaqabi Humoud Y Al Sabah Marwan Alkandari Hassan Abdelnaby Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11